Yochai Basel

Title: Yochai Basel: Innovator in Pharmaceutical Compounds

Introduction

Yochai Basel is a notable inventor based in Rechovot, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate heparanase activity. His work is crucial for advancing treatments for various diseases associated with heparanase and heparin-binding proteins.

Latest Patents

Yochai Basel holds a patent for "Rigidified compounds for modulating heparanase activity." This patent discloses novel rigidified compounds featuring a rhodanine-like residue and at least one aryl or heteroaryl residue linked to the rhodanine-like residue. The core structure of these compounds is characterized by having one or zero free-to-rotate bonds. Additionally, the patent outlines pharmaceutical compositions containing these rigidified compounds and their applications in treating heparanase-associated diseases and disorders.

Career Highlights

Yochai Basel is associated with Insight Biopharmaceuticals Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective treatments that leverage the unique properties of his patented compounds.

Collaborations

Yochai has collaborated with notable colleagues, including Joel M Van Gelder and Joseph Y Klein. These partnerships enhance the research and development efforts within the pharmaceutical industry.

Conclusion

Yochai Basel's contributions to pharmaceutical innovations, particularly through his patent on rigidified compounds, demonstrate his commitment to advancing medical treatments. His work is vital for addressing diseases linked to heparanase and heparin-binding proteins.